Enterprise Advantage

Research and Development Capability

Drug polypeptide

Functional polypeptide

Polypeptide synthesis amino acid raw material

PMO and PNA monomers

Macrocyclic bifunctional chelate

Custom peptide service

Customized service for modified proteins

Special amino acid customization service

Small molecule customization service

Peptide coupling custom service

Name
CAS
Sequence
Purity

Angiotensin I/II (1-7)
51833-78-4
DRVYIHP-OH (trifluoroacetate salt)
95%

Fusion Inhibitory Peptide
75539-79-6
Z-fFG-OH
95%

Angiotensin II (human)
4474-91-3
DRVYIHPF-OH (trifluoroacetate salt)
95%

Angiotensin I (human)
70937-97-2
DRVYIHPFHL-OH (trifluoroacetate salt)
95%

4 in total
1

product

Drug polypeptide

Functional polypeptide

Diabetic polypeptide

Alzheimer's disease peptides

Multiple sclerosis polypeptide

Antibacterial polypeptide

Gastrointestinal disease polypeptide

Hormone polypeptide

Cardiovascular disease polypeptide

COVID-19 polypeptide

Hematological peptides

Apoptosis polypeptide

Inflammation-related peptides

Cancer treatment peptides

Protein kinase phosphatase polypeptide

Fluorescent resonance energy transfer substrate polypeptide

Immune regulatory peptides

Enzyme inhibitor polypeptide

Rgd-related peptides

Neuropeptide Polypeptide

Other polypeptides

Polypeptide synthesis amino acid raw material

PMO and PNA monomers

Macrocyclic bifunctional chelate

About

Enterprise Advantage

Research and Development Capability

Products

Drug polypeptide

Functional polypeptide

Polypeptide synthesis amino acid raw material

PMO and PNA monomers

Macrocyclic bifunctional chelate

Services

Custom peptide service

Customized service for modified proteins

Special amino acid customization service

Small molecule customization service

Peptide coupling custom service

News

Contact

CopyRight © 2022-2025 All Rights Reserved. Combiosz Power by：SoftMoon

Consultation Hotline

+86.17751202919

WhatsApp